skip to Main Content

Dr. Morris has multiple decades of industry experience in the clinical research and development fields. After spending nearly 10 years with GSK as a Senior Director of Oncology, Dr. Morris served as Senior Director at MedImmune and VP of Clinical Development at G1 Therapeutics, where she led trilaciclib through the first indication’s NDA. Dr. Morris received her MD, PhD in molecular virology from Case Western Reserve University School of Medicine and completed her internal medicine residency and oncology fellowship at The University of North Carolina at Chapel Hill.

Back To Top
×Close search